Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone + Clemastine in Allergic Dermatitis
NCT01239719Phase 3Unknown
- Sponsor
- Azidus Laboratories Limited
- Start
- Mar 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of clemastine in allergic contact dermatitis (ACD), sponsored by Azidus Laboratories Limited. Status: unknown.
02
Drugs
clemastine
03
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT01239719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239719.